Clinical Trials on Benign Prostatic Hyperplasia (BPH)

Total 635 results

Ain Shams University

Completed

HoLEP vs mTURP in Management of Benign Prostatic Hyperplasia

Prostatic Hyperplasia

Egypt
Boehringer Ingelheim

Completed

Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.

Prostatic Hyperplasia
Marmara University

Unknown

Benign Prostatic Hyperplasia and Glycosaminoglycan

Prostatic Hyperplasia

Turkey
GlaxoSmithKline

Completed

Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects

Prostatic Hyperplasia

Japan
GlaxoSmithKline

Terminated

Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia (FDC114785)

Prostatic Hyperplasia

Vietnam
GlaxoSmithKline

Completed

Prospective Sexual Function Study for BPH Subjects

Prostatic Hyperplasia

Germany, Australia, Netherlands, Spain, Hungary, France, Greece
John D Louie

Withdrawn

Prostate Artery Embolization for the Treatment of Benign Prostatic Hyperplasia

Prostatic Hyperplasia

United States
GlaxoSmithKline

Completed

Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS

Prostatic Hyperplasia

United Kingdom
GlaxoSmithKline

Completed

A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State

Prostatic Hyperplasia

United States
GlaxoSmithKline

Completed

Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence

Prostatic Hyperplasia
GlaxoSmithKline

Completed

Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment

Prostatic Hyperplasia

United States, Netherlands, Spain, Taiwan, Bulgaria, Estonia, Hungary, Italy, Belgium, Thailand, Israel, Germany, Canada, Korea, Republic of, Norway, Finland, Russian Federation, Romania, Brazil, France, Slovakia, Philippines, South... and more
GlaxoSmithKline

Completed

Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels

Prostatic Hyperplasia

United States
Boehringer Ingelheim

Completed

Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia

Prostatic Hyperplasia
Sanofi

Completed

Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia

Prostatic Hyperplasia

Japan
Milkhaus Laboratory

Unknown

A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).

Prostatic Hyperplasia

United States
Hospital de Clinicas de Porto Alegre
Federal University of Rio Grande do Sul

Completed

Teleconsultation in Counter-reference Between Tertiary and Primary Care for Patients With Benign Prostatic Hyperplasia

Prostatic Hyperplasia

Brazil
Groupe Hospitalier Paris Saint Joseph

Withdrawn

Evaluation of the Satisfaction of the Patients Operated for a Mild Hyperplasie of the Prostate by Laser in Ambulatory Surgery

Prostatic Hyperplasia
South Florida Medical Imaging, PA

Terminated

Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 Grams

Prostatic Hyperplasia

United States
GlaxoSmithKline

Completed

This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples

Prostatic Hyperplasia

China
Mansoura University

Completed

HoLEP (50W) vs. HoLEP (100W) for Treatment of BPH

Prostatic Hyperplasia

Egypt
GlaxoSmithKline

Completed

A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.

Prostatic Hyperplasia

United States
GlaxoSmithKline

Completed

Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use

Prostatic Hyperplasia
Xiangfu Zhou

Unknown

The Influence of Benign Prostatic Hyperplasia on Bladder Function

Prostatic Hyperplasia

China
Mansoura University

Unknown

Ejaculatory Sparing vs. Non-ejaculatory Sparing GreenLight Laser Photoselective Vaporization of the Prostate

Prostatic Hyperplasia

Egypt
Boehringer Ingelheim

Completed

Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS)

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade

Prostatic Hyperplasia
GlaxoSmithKline

Completed

Drug Use Investigation for AVOLVE(BPH)

Prostatic Hyperplasia
The Catholic University of Korea

Unknown

Functional Changes of Urogenital System After Holmium Laser Prostatectomy

Prostatic Hyperplasia

Korea, Republic of
Sanofi

Completed

ALF-ONE : ALFuzosin ONcE Daily

Prostatic Hyperplasia
Sanofi

Completed

Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin (SAMBA-Thailand)

Prostatic Hyperplasia

Thailand
Handok Inc.

Completed

Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study

Prostatic Hyperplasia

Korea, Republic of
Sanofi

Terminated

ALF-STONE: Alfuzosin in Uretheric Stones

Prostatic Hyperplasia

Portugal
University of Illinois at Chicago
National Cancer Institute (NCI)

Completed

Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia

Prostate Cancer | Nonmalignant Neoplasm
GlaxoSmithKline

Completed

Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)

Prostatic Hyperplasia | Prostatitis

Italy
GlaxoSmithKline

Completed

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

Prostatic Hyperplasia

Australia
GlaxoSmithKline

Completed

SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin

Prostatic Hyperplasia

Brazil
GlaxoSmithKline

Completed

A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. (ARI114694)

Prostatic Hyperplasia

Australia
GlaxoSmithKline

Completed

Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database

Prostatic Hyperplasia
Terumo Medical Corporation

Completed

An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres (RAVI Registry)

Benign Prostatic Hyperplasia | Arteriovenous Malformations | Uterine Fibroid | Hypervascular Tumors

United States
Can-Am HIFU Inc.

Recruiting

Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).

Urologic Diseases

Canada
GlaxoSmithKline

Completed

Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males. (ARI115707)

Prostatic Hyperplasia

Australia
GlaxoSmithKline

Completed

Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia

Prostatic Hyperplasia
GlaxoSmithKline

Completed

Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database

Prostatic Hyperplasia
Can-Am HIFU Inc.

Recruiting

Aquablation in Benign Prostatic Hyperplasia in Canada

Urologic Diseases

Canada
GlaxoSmithKline

Completed

Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects (ARI115148)

Prostatic Hyperplasia

United States
GlaxoSmithKline

Completed

Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic Hyperplasia

Prostatic Hyperplasia
GlaxoSmithKline

Completed

Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment

Prostatic Hyperplasia

3

Subscribe